KEGG: spo:SPBC13E7.06
STRING: 4896.SPBC13E7.06.1
The mug172 protein (UniProt ID: Q9P6R4) is expressed in Schizosaccharomyces pombe (fission yeast). It functions as part of cellular mechanisms that are activated during meiosis. The protein is classified among the "mug" (meiotically upregulated gene) proteins in S. pombe, suggesting its expression increases during sexual differentiation and meiotic processes . While mug172's precise function remains under investigation, research tools like the mug172 antibody enable researchers to study its expression patterns, localization, and potential interactions with other proteins during cell division and stress responses.
The mug172 antibody has been validated for the following applications:
| Application | Validation Status | Recommended Dilution |
|---|---|---|
| ELISA | Validated | Optimize per protocol |
| Western Blot (WB) | Validated | Optimize per protocol |
The antibody is specifically tested against Schizosaccharomyces pombe (strain 972/ATCC 24843) . For research applications beyond these validated methods, preliminary testing and optimization are strongly recommended to ensure specificity and sensitivity.
Upon receipt, the mug172 antibody should be stored at -20°C or -80°C to maintain its activity and specificity. The antibody is provided in liquid form containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . Researchers should avoid repeated freeze-thaw cycles as this can significantly degrade antibody performance. For laboratories requiring frequent access to the antibody, aliquoting into single-use volumes before freezing is recommended to minimize freeze-thaw cycles and extend the functional life of the antibody.
When designing Western blot experiments with mug172 antibody, consider the following methodological approach:
Sample preparation: Extract proteins from S. pombe cells using appropriate lysis buffers that preserve protein integrity while efficiently disrupting the yeast cell wall.
Control selection: Include both positive controls (purified recombinant mug172 protein if available) and negative controls (extracts from strains where mug172 is deleted or not expressed).
Gel electrophoresis parameters: Use 10-12% SDS-PAGE gels for optimal resolution of the mug172 protein.
Transfer conditions: For yeast proteins, semi-dry transfer at 15V for 30-40 minutes or wet transfer at 30V overnight at 4°C is recommended.
Blocking optimization: Test blocking with 5% non-fat dry milk or 3-5% BSA in TBST to determine which provides better signal-to-noise ratio.
Antibody incubation: Start with a 1:1000 dilution of the primary antibody and optimize as needed based on signal strength and background levels .
Detection method: Use HRP-conjugated secondary antibodies with appropriate chemiluminescent substrates for visualization, similar to methods used for other antibodies in published research .
When optimizing ELISA protocols with mug172 antibody, consider these critical factors:
Coating concentration: Determine optimal antigen coating concentration (typically 1-10 μg/ml) through titration experiments.
Antibody dilution series: Create a dilution series (1:500 to 1:10,000) to establish the optimal working concentration that provides maximal specific signal with minimal background.
Incubation conditions: Test both room temperature and 4°C incubations with varying durations (1-16 hours) to identify optimal binding conditions.
Buffer optimization: Compare different blocking buffers (BSA, casein, commercial formulations) and washing stringency to improve sensitivity.
Signal detection: When developing standard curves, use the appropriate curve-fitting model as seen in other antibody research: y = (A - D)/(1 + (x/C)^B) + D, where parameters should be optimized for your specific assay conditions .
Cross-reactivity assessment: Test potential cross-reactivity with related proteins to ensure specificity.
Reproducibility verification: Perform replicate experiments to ensure consistent results, with CV values preferably below 10%.
To ensure experimental validity when using mug172 antibody, incorporate these essential controls:
Positive control: Include samples containing known mug172 protein expression.
Negative control: Use samples from organisms or cell lines that don't express mug172 or from mug172 knockout strains.
Antibody specificity control: Include a normal rabbit IgG control at the same concentration as the primary antibody to identify potential non-specific binding .
Secondary antibody control: Run samples with secondary antibody only (no primary) to identify non-specific secondary antibody binding.
Loading/normalization control: Use established housekeeping proteins appropriate for fission yeast when performing Western blots.
Peptide competition assay: If available, pre-incubate the antibody with purified mug172 peptide to demonstrate binding specificity.
Dose-response relationship: For quantitative applications, establish a standard curve using recombinant protein at known concentrations.
These controls align with standard practices observed in published antibody research protocols .
False negative results when using mug172 antibody may stem from several sources:
Protein denaturation issues: The antibody recognizes a recombinant Schizosaccharomyces pombe mug172 protein, so ensure denaturation conditions don't destroy the epitope. Test multiple denaturation protocols if initial attempts fail.
Low protein expression: mug172 may have low basal expression in vegetative cells. Consider using conditions that upregulate its expression, particularly meiotic induction protocols, as mug172 is a meiotically upregulated gene.
Inefficient extraction: S. pombe cell walls are robust; ensure your extraction protocol effectively liberates intracellular proteins. Consider using glass bead lysis or enzymatic cell wall digestion methods.
Buffer incompatibility: The antibody is stored in a specific buffer (50% Glycerol, 0.01M PBS, pH 7.4) . Certain experimental buffers may interfere with binding. Test alternative buffer systems if negative results persist.
Antibody degradation: Improper storage or excessive freeze-thaw cycles can inactivate antibodies. Use freshly thawed aliquots and verify antibody activity with a positive control.
Detection sensitivity issues: If signal is weak, consider using signal amplification systems such as biotin-streptavidin or tyramide signal amplification to enhance detection.
Post-translational modifications: If the protein undergoes modifications that mask the epitope, consider testing multiple experimental conditions or extraction methods.
To improve signal-to-noise ratio when using mug172 antibody in Western blots:
Optimize blocking conditions: Test different blocking agents (5% milk, 3-5% BSA, commercial blocking buffers) to identify which provides the lowest background with mug172 antibody.
Adjust antibody concentration: Titrate the antibody concentration to find the optimal dilution that provides specific signal with minimal background.
Increase washing stringency: Add additional washing steps or increase detergent concentration (0.1% to 0.3% Tween-20) in wash buffers to reduce non-specific binding.
Optimize incubation times and temperatures: Test different incubation conditions for both primary and secondary antibodies (4°C overnight vs. room temperature for shorter periods).
Use high-quality reagents: Ensure all buffers and reagents are fresh and properly prepared to minimize background issues.
Consider membrane type: Compare PVDF and nitrocellulose membranes to determine which provides better results with this particular antibody.
Employ gradient optimization: Similar to approaches used in other antibody studies, consider testing a range of conditions systematically to identify optimal parameters .
To validate the specificity of results obtained with mug172 antibody, employ these complementary approaches:
Genetic validation: Compare results between wild-type strains and mug172 deletion/knockdown strains to confirm signal specificity.
Peptide competition assay: Pre-incubate the antibody with purified mug172 peptide before the experiment; a specific signal should be significantly reduced or eliminated.
Alternative antibody comparison: If available, test another antibody against mug172 or an epitope-tagged version of the protein to confirm consistent results.
Immunoprecipitation followed by mass spectrometry: Perform IP with the antibody and analyze precipitated proteins by mass spectrometry to confirm identity.
Expression correlation: Verify that signal intensity correlates with expected expression patterns, particularly during meiosis when mug172 is expected to be upregulated.
Orthogonal techniques: Confirm antibody results using orthogonal methods such as RNA expression analysis or fluorescent protein tagging.
Cross-species reactivity assessment: Test the antibody against closely related species to evaluate specificity, although this particular antibody is specifically raised against S. pombe strain 972/ATCC 24843 .
For studying protein-protein interactions involving mug172, consider these methodological approaches:
Co-immunoprecipitation (Co-IP):
Use mug172 antibody to pull down mug172 protein complexes from S. pombe lysates
Analyze co-precipitated proteins by mass spectrometry or Western blotting
Include stringent controls (IgG control, mug172-deletion strains)
Consider crosslinking proteins prior to lysis for capturing transient interactions
Proximity ligation assays (PLA):
Combine mug172 antibody with antibodies against suspected interaction partners
Optimize fixation conditions specific for yeast cells (typically formaldehyde-based)
Use appropriate permeabilization methods to ensure antibody access while preserving structure
Pull-down validation methods:
Validate interactions identified through Co-IP using recombinant protein pull-downs
Perform reciprocal Co-IPs with antibodies against identified interaction partners
Consider using epitope-tagged versions of mug172 for complementary approaches
Functional validation:
Design experiments to test the biological significance of identified interactions
Use genetic approaches (double mutants, suppressor screens) to validate functional relationships
Advanced researchers might consider adapting transposon-based expression systems similar to those used in other protein studies to create tagged versions of mug172 for interaction studies.
When adapting mug172 antibody for immunofluorescence microscopy in S. pombe:
Cell wall digestion optimization: S. pombe cell walls require controlled digestion for antibody penetration without damaging cellular structures. Test different concentrations of zymolyase or lysing enzymes and digestion times.
Fixation method selection: Compare different fixatives:
Methanol fixation: Good for preserving antigen recognition but can disrupt membrane structures
Paraformaldehyde (3-4%): Better for membrane preservation but may require additional permeabilization
Glutaraldehyde combinations: Consider for improved structural preservation
Permeabilization optimization: Test different permeabilization agents (0.1% Triton X-100, 0.5% Saponin) and times to balance antibody access with structural preservation.
Antibody concentration: Start with higher concentrations (1:100-1:500) than used for Western blotting and optimize through titration.
Signal amplification: Consider tyramide signal amplification if direct detection yields weak signals.
Co-localization studies: When performing co-localization with other cellular markers, carefully select fluorophore combinations to minimize spectral overlap.
3D imaging considerations: For detailed localization studies, consider acquiring Z-stacks and using deconvolution algorithms to improve resolution.
Controls for autofluorescence: S. pombe can exhibit autofluorescence; include no-antibody controls to distinguish true signal from background.
To study mug172 expression dynamics during cell cycle or stress response:
Synchronization protocols:
Implement established cell synchronization methods for S. pombe (nitrogen starvation, temperature-sensitive cdc mutants, or elutriation)
Collect samples at defined timepoints after synchronization
Verify synchronization efficiency using established markers
Quantitative Western blotting:
Use mug172 antibody in quantitative Western blots
Include appropriate loading controls (α-tubulin, GAPDH)
Apply digital imaging and quantification software for precise measurement
Consider including recombinant protein standards for absolute quantification
Flow cytometry adaptation:
Optimize fixation and permeabilization for intracellular staining
Test different concentrations of mug172 antibody with fluorophore-conjugated secondary antibodies
Include appropriate compensation and FMO controls
Combine with DNA content staining to correlate with cell cycle phases
Stress response analysis:
Define clear experimental parameters for stress induction (oxidative, heat, osmotic stress)
Include positive controls (known stress-responsive proteins)
Consider time-course experiments to capture dynamic responses
Compare multiple stress conditions to identify specific vs. general responses
Quantitative analysis recommendations:
Perform at least three biological replicates
Apply appropriate statistical tests for time-course data (repeated measures ANOVA)
Consider modeling approaches to characterize expression dynamics
This approach adapts methodologies similar to those used for studying antibody expression in other systems but tailored specifically for investigating mug172 in fission yeast.
To effectively integrate mug172 protein data with transcriptomic analyses:
Correlation analysis framework:
Collect matched samples for both protein (Western blot with mug172 antibody) and RNA analysis
Generate quantitative protein expression data through calibrated Western blots
Normalize protein expression against appropriate housekeeping proteins
Compare protein levels with mRNA expression patterns to identify potential post-transcriptional regulation
Temporal studies methodology:
Design time-course experiments capturing both mRNA and protein levels
Calculate time delays between mRNA and protein expression changes
Apply mathematical models to characterize the relationship between transcription and translation regulation
Data integration approaches:
Utilize computational tools designed for multi-omics data integration
Consider principal component analysis or similar dimension reduction techniques to identify patterns
Implement network analysis approaches to position mug172 within regulatory networks
This integration approach can reveal whether mug172 is primarily regulated at the transcriptional level or if post-transcriptional mechanisms significantly influence its expression patterns.
While mug172 has not been specifically characterized as a DNA-binding protein, researchers interested in exploring potential chromatin associations should consider these methodological adaptations:
Protocol optimization requirements:
Test different crosslinking conditions (1-3% formaldehyde, 5-20 minutes)
Optimize sonication parameters specifically for S. pombe chromatin
Determine optimal antibody concentration through titration experiments
Include appropriate controls (IgG control, input normalization)
Validation approaches:
Implement spike-in controls with known chromatin-associated proteins
Perform sequential ChIP (re-ChIP) if investigating co-localization with known factors
Validate findings with orthogonal methods (e.g., DamID)
Data analysis recommendations:
Apply appropriate peak calling algorithms
Conduct motif analysis on identified binding regions
Integrate with available epigenomic datasets
Researchers should note that this application would be considered exploratory until direct DNA-binding activity of mug172 is established.